Screening and identifying diabetes in optometric practice: A prospective study

British Journal of General Practice

Volumn 61, Issue 588, 2011, Pages

  Howse, Jennifer H ^a   Jones, Steve ^b   Hungin, A Pali S ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus, type 2; Optometry; Prediabetes; Primary care; Screening

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CAPILLARY BLOOD; CONTROLLED STUDY; DIABETES MELLITUS; FEASIBILITY STUDY; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OPTOMETRY; PROSPECTIVE STUDY; RISK FACTOR; SCREENING; UNITED KINGDOM;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; ENGLAND; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OPTOMETRY; PREDIABETIC STATE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 80052788490     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X583227     Document Type: Article

References (32)

1. Thomas MC, Walker MK, Emberson JR, et al. Prevalence of undiagnosed type 2 diabetes and impaired fasting glucose in older British men and women. Diabet Med 2005; 22(6): 789-793. (Pubitemid 40805903)
2. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance -The Australian diabetes, obesity and lifestyle study. Diabetes Care 2002; 25(5): 829-834. (Pubitemid 41094278)
3. Pierce MB, Zaninotto P, Steel N, Mindell J. Undiagnosed diabetes-data from the English longitudinal study of ageing. Diabet Med 2009; 26(7): 679-685.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9): 1414-1431. (Pubitemid 28405191)
5. Goyder E, Wild S, Fischbacher C, et al. Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England. Fam Pract 2008; 25(5): 370-375.
6. Marteau TM, Mann E, Prevost AT, et al. Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.BMJ 2010; 340: c2138.
7. Diabetes UK. Our 2 minute test. http://www.diabetes.org.uk/measure%2Dup/ (accessed 6 Jun 2011).
8. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997; 46(4): 701-710. (Pubitemid 27143390)
9. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21(4): 518-524. (Pubitemid 28172927)
10. Hadaegh F, Bozorgmanesh MR, Ghasemi A, et al. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 2008; 8: 176.
11. Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 2001; 322(7292): 986-988. (Pubitemid 32374692)
12. Department of Health. Putting prevention first -NHS health check: vascular risk assessment and management best practice guidance. London: Department of Health, 2009.
13. Lawal AG, Patel MG, Wong ICK, Chrystyn H. Opportunistic screening for type 2 diabetes within inner city community pharmacies. Int J Pharm Pract 2003; 11(Suppl): R10.
14. Gill GV, Lishman M, Kaczmarczyk E, Tesfaye S. Targeted screening for diabetes in community chiropody clinics. QJM 1996; 89(3): 229-232. (Pubitemid 26086143)
15. Krass I, Mitchell B, Clarke P, et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabet Res Clin Pract 2007; 75(3): 339-347. (Pubitemid 46074203)
16. Hersberger KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes -evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 2006; 28(3): 171-179. (Pubitemid 44584052)
17. Diabetes UK and Royal Pharmaceutical Society of Great Britain. Early identification of diabetes for community pharmacists. London: Diabetes UK, 2006.
18. Borrell LN, Kunzel C, Lamster I, Lalla E. Diabetes in the dental office: using NHANES III to estimate the probability of undiagnosed disease. J Periodont Res 2007; 42(6): 559-565.
19. The Information Centre. Sight test volume and workforce survey 2005/06. Leeds: The Information Centre, 2006. http://www.ic.nhs.uk/webfiles/publications/ sighttestvolandwforce/SightTestsV olumeAndWorkforceReport241006-PDF.pdf (accessed 6 Jun 2011).
20. McCarty CA, McKay R, Keeffe JE. Management of diabetic retinopathy by Australian optometrists. Working Group on Evaluation of NHMRC Retinopathy Guideline Distribution. National Health and Medical Research Council. Aust N Z J Ophthalmol 1999; 27(6): 404-409.
21. Howse JH, Jones S, Hungin APS. Screening and diagnosing diabetes in optometrists' practices: an evaluation of perceptions, attitudes and beliefs. Practical Diabetes International 2010; 27: 55-58.
22. Hulme SA, Tin-U A, Hardy KJ, Joyce PW. Evaluation of a district-wide screening programme for diabetic retinopathy utilizing trained optometrists using slit-lamp and Volk lenses. Diabet Med 2002; 19(9): 741-745. (Pubitemid 35013852)
23. Association of Public Health Observatories. Health profile. Hartlepool 2009. http://www.apho.org.uk/resource/view.aspx?RID=50215&SEARCH=hartlepool &SPEAR= (accessed 6 Jun 2011).
24. Association of Public Health Observatories. Health profile. County Durham 2009. http://www.apho.org.uk/resource/view.aspx?RID=50215&SEARCH=county+dur ham&SPEAR= (accessed 6 Jun 2011).
25. Association of Public Health Observatories. Health profile. Redcar and Cleveland 2009. http://www.apho.org.uk/resource/view.aspx?RID=50215&SEARCH= redcar+an d+cleveland&SPEAR= (accessed 6 Jun 2011).
26. Christensen J, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004; 47(9): 1566-1573. (Pubitemid 39371639)
27. Wylie G, Hungin APS, Neely J. Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions. BMJ 2002; 324(7347): 1190-1192. (Pubitemid 34547921)
28. Williams R, Rapport F, Elwyn G, et al. The prevention of type 2 diabetes: general practitioner and practice nurse opinions. Br J Gen Pract 2004; 54(504): 531-535. (Pubitemid 38931350)
29. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27(suppl 1): S11-14.
30. Howse JH, Jones S, Hungin APS. Screening for diabetes in optometry practices: acceptability to users. Ophthalmic Physiol Opt 2011. doi: 10.1111/j.1475-1313.2011.00826.x. [Epub ahead of print]
31. Saudek CD, Herman WH, Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008; 93(7): 2447-2453. (Pubitemid 352008502)
32. Sagan W, Schwader K. Non-contact tonometry by assistants. Am J Optom Physiol Opt 1975; 52(4): 288-290.